157 Endocrine and Metabolic Alterations following Deep Brain Stimulation in Anorexia Nervosa REFERENCES 1. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Current Opinion in Psychiatry. 2006;19(4):389-94. 2. Sullivan PF. Mortality in anorexia nervosa. The American journal of psychiatry. 1995;152(7):1073-4. 3. Association AP. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC2013. 4. Steinhausen HC. Outcome of eating disorders. Child and adolescent psychiatric clinics of North America. 2009;18(1):225-42. 5. Oudijn MS, Mocking RJT, Wijnker RR, Lok A, Schuurman PR, van den Munckhof P, et al. Deep brain stimulation of the ventral anterior limb of the capsula interna in patients with treatmentrefractory anorexia nervosa. Brain Stimul. 2021;14(6):1528-30. 6. Karaszewska D, Cleintuar P, Oudijn M, Lok A, van Elburg A, Denys D, Mocking R. Efficacy and safety of deep brain stimulation for treatment-refractory anorexia nervosa: a systematic review and meta-analysis. Transl Psychiatry. 2022;12(1):333. 7. Cost J, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa. Cleve Clin J Med. 2020;87(6):361-6. 8. Puckett L, Grayeb D, Khatri V, Cass K, Mehler P. A Comprehensive Review of Complications and New Findings Associated with Anorexia Nervosa. J Clin Med. 2021;10(12). 9. Misra M, Klibanski A. Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol. 2014;2(7):581-92. 10. Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol. 2017;13(3):174-86. 11. Støving RK. MECHANISMS IN ENDOCRINOLOGY: Anorexia nervosa and endocrinology: a clinical update. Eur J Endocrinol. 2019;180(1):R9-r27. 12. Fazeli PK, Klibanski A. Determinants of GH resistance in malnutrition. J Endocrinol. 2014;220(3):R57-65. 13. Khalil RB, El Hachem C. Adiponectin in eating disorders. Eat Weight Disord. 2014;19(1):3-10. 14. Pruccoli J, Parmeggiani A, Cordelli DM, Lanari M. The Role of the Noradrenergic System in Eating Disorders: A Systematic Review. Int J Mol Sci. 2021;22(20). 15. Kontis D, Theochari E. Dopamine in anorexia nervosa: a systematic review. Behav Pharmacol. 2012;23(5-6):496-515. 16. Berner LA, Brown TA, Lavender JM, Lopez E, Wierenga CE, Kaye WH. Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin. Mol Cell Endocrinol. 2019;497:110320. 17. Södersten P, Bergh C, Leon M, Zandian M. Dopamine and anorexia nervosa. Neuroscience and biobehavioral reviews. 2016;60:26-30. 18. de Koning PP, Figee M, Endert E, van den Munckhof P, Schuurman PR, Storosum JG, et al. Rapid effects of deep brain stimulation reactivation on symptoms and neuroendocrine parameters in obsessive-compulsive disorder. Transl Psychiatry. 2016;6(1):e722. 19. de Koning PP, Figee M, Endert E, Storosum JG, Fliers E, Denys D. Deep brain stimulation for obsessive-compulsive disorder is associated with cortisol changes. Psychoneuroendocrinology. 2013;38(8):1455-9. 20. Mocking RJ, Assies J, Lok A, Ruhé HG, Koeter MW, Visser I, et al. Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices. Lipids. 2012;47(5):541-7. 21. Jacoangeli F, Masala S, Staar Mezzasalma F, Fiori R, Martinetti A, Ficoneri C, et al. Amenorrhea after weight recover in anorexia nervosa: role of body composition and endocrine abnormalities. Eat Weight Disord. 2006;11(1):e20-6.
RkJQdWJsaXNoZXIy MjY0ODMw